ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF

The instant disclosure provides antibodies that specifically bind to CD96 (e.g., human CD96) and antagonize CD96 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies...

Full description

Saved in:
Bibliographic Details
Main Authors Bushell, K. Mark, Gombos, Randi Barbara, Briend, Emmanuel Cyrille Pascal, Chand, Dhan Sidhartha, Ramsay, Nicola Anne, Ignatovich, Olga
Format Patent
LanguageEnglish
Published 08.04.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The instant disclosure provides antibodies that specifically bind to CD96 (e.g., human CD96) and antagonize CD96 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Bibliography:Application Number: US202017007238